BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

Cancer Gene Therapy, Published online: 25 December 2023; doi:10.1038/s41417-023-00720-0BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Source Type: research